Page 10 - Protara Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Protara therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Protara Therapeutics Today - Breaking & Trending Today

Protara Therapeutics (NASDAQ:TARA) Stock Price Up 6.5%

Shares of Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) rose 6.5% during trading on Monday . The company traded as high as $2.54 and last traded at $2.47. Approximately 48,083 shares changed hands during mid-day trading, an increase of 61% from the average daily volume of 29,836 shares. The stock had previously closed at […] ....

Protara Therapeutics Inc , Virtu Financial , Privium Fund Management United Kingdom Ltd , Renaissance Technologies , Protara Therapeutics , Get Free Report , Fund Management United Kingdom Ltd , Protara Therapeutics Daily ,

Protara Therapeutics (NASDAQ:TARA) & VectivBio (NASDAQ:VECT) Critical Comparison

Protara Therapeutics (NASDAQ:TARA – Free Report) and VectivBio (NASDAQ:VECT – Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership. Analyst Ratings This is a summary of current recommendations for Protara […] ....

New York , United States , Vectivbio Holding , Artara Therapeutics Inc , Protara Therapeutics Inc , Protara Therapeutics , Free Report , Given Protara Therapeutic , Artara Therapeutics , Protara Therapeutics Daily ,

Opaleye Management Inc. Cuts Stock Holdings in ProQR Therapeutics (NASDAQ:PRQR)

Opaleye Management Inc. decreased its stake in Protara Therapeutics, Inc. (NASDAQ:TARA – Get Rating) by 0.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,692,594 shares of the company’s stock after selling 15,473 shares during the period. Protara Therapeutics comprises about 2.5% of […] ....

Opaleye Management Inc , Protara Therapeutics Inc , Privium Fund Management United Kingdom Ltd , Protara Therapeutics Company Profile , Virtu Financial , Exchange Commission , Renaissance Technologies , Opaleye Management , Protara Therapeutics , Get Rating , Fund Management United Kingdom Ltd , Therapeutics Trading Down , Visit Holdingschannel , Protara Therapeutics Daily ,

Protara Therapeutics, Inc. (NASDAQ:TARA) Short Interest Update

Protara Therapeutics, Inc. (NASDAQ:TARA – Get Rating) was the recipient of a large growth in short interest in April. As of April 30th, there was short interest totalling 102,200 shares, a growth of 34.1% from the April 15th total of 76,200 shares. Approximately 1.2% of the shares of the company are sold short. Based on […] ....

Protara Therapeutics Inc , Virtu Financial , Renaissance Technologies , Privium Fund Management United Kingdom Ltd , Protara Therapeutics , Get Rating , Therapeutics Trading Down , Protara Therapeutics Daily , Nasdaq Tara ,

Protara Therapeutics, Inc. (NASDAQ:TARA) Short Interest Update

Protara Therapeutics, Inc. (NASDAQ:TARA – Get Rating) was the target of a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 102,200 shares, an increase of 34.1% from the April 15th total of 76,200 shares. Approximately 1.2% of the company’s stock are sold short. Based […] ....

Privium Fund Management United Kingdom Ltd , Protara Therapeutics Company Profile , Virtu Financial , Renaissance Technologies , Protara Therapeutics Inc , Protara Therapeutics , Get Rating , Fund Management United Kingdom Ltd , Protara Therapeutics Daily , Nasdaq Tara ,